abstract |
The present invention relates to novel P2X7R antagonists, which are indole-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions containing such compounds, and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity. |